Cargando…
Gene Expression as a Guide to the Development of Novel Therapies in Primary Glomerular Diseases
Despite improvements in understanding the pathogenic mechanisms of primary glomerular diseases, therapy still remains nonspecific. We sought to identify novel therapies targeting kidney-intrinsic injury of distinct primary glomerulonephritides through computational systems biology approaches. We def...
Autores principales: | Garantziotis, Panagiotis, Doumas, Stavros A. P., Boletis, Ioannis, Frangou, Eleni |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8197155/ https://www.ncbi.nlm.nih.gov/pubmed/34073694 http://dx.doi.org/10.3390/jcm10112262 |
Ejemplares similares
-
Molecular Taxonomy of Systemic Lupus Erythematosus Through Data-Driven Patient Stratification: Molecular Endotypes and Cluster-Tailored Drugs
por: Garantziotis, Panagiotis, et al.
Publicado: (2022) -
Kidney transplantation outcomes in patients with IgA nephropathy and other glomerular and non-glomerular primary diseases in the new era of immunosuppression
por: Lionaki, Sophia, et al.
Publicado: (2021) -
Restoration of aberrant gene expression of monocytes in systemic lupus erythematosus via a combined transcriptome-reversal and network-based drug repurposing strategy
por: Nikolakis, Dimitrios, et al.
Publicado: (2023) -
Pregnancy in Women With Preexisting Glomerular Diseases: A Single-Center Experience
por: Marinaki, Smaragdi, et al.
Publicado: (2022) -
B Cell Depletion: Rituximab in Glomerular Disease and Transplantation
por: Marinaki, S., et al.
Publicado: (2013)